vs

Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and PEGASYSTEMS INC (PEGA). Click either name above to swap in a different company.

PEGASYSTEMS INC is the larger business by last-quarter revenue ($430.0M vs $379.6M, roughly 1.1× DIVERSIFIED HEALTHCARE TRUST). PEGASYSTEMS INC runs the higher net margin — 7.6% vs -5.6%, a 13.2% gap on every dollar of revenue. On growth, DIVERSIFIED HEALTHCARE TRUST posted the faster year-over-year revenue change (-0.0% vs -9.6%). PEGASYSTEMS INC produced more free cash flow last quarter ($206.5M vs $-166.4M). Over the past eight quarters, PEGASYSTEMS INC's revenue compounded faster (10.7% CAGR vs 1.2%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Pegasystems Inc. (Pega) is a global software company based in Waltham, Massachusetts, in the United States, and founded in 1983. The company has been publicly traded since 1996 as PEGA (NASDAQ). Pega is a low-code platform for workflow automation and generative AI-powered decision-making for businesses.

DHC vs PEGA — Head-to-Head

Bigger by revenue
PEGA
PEGA
1.1× larger
PEGA
$430.0M
$379.6M
DHC
Growing faster (revenue YoY)
DHC
DHC
+9.6% gap
DHC
-0.0%
-9.6%
PEGA
Higher net margin
PEGA
PEGA
13.2% more per $
PEGA
7.6%
-5.6%
DHC
More free cash flow
PEGA
PEGA
$373.0M more FCF
PEGA
$206.5M
$-166.4M
DHC
Faster 2-yr revenue CAGR
PEGA
PEGA
Annualised
PEGA
10.7%
1.2%
DHC

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DHC
DHC
PEGA
PEGA
Revenue
$379.6M
$430.0M
Net Profit
$-21.2M
$32.8M
Gross Margin
75.2%
Operating Margin
-12.6%
8.6%
Net Margin
-5.6%
7.6%
Revenue YoY
-0.0%
-9.6%
Net Profit YoY
75.7%
EPS (diluted)
$-0.09
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHC
DHC
PEGA
PEGA
Q1 26
$430.0M
Q4 25
$379.6M
$504.3M
Q3 25
$388.7M
$381.4M
Q2 25
$382.7M
$384.5M
Q1 25
$386.9M
$475.6M
Q4 24
$379.6M
$490.8M
Q3 24
$373.6M
$325.1M
Q2 24
$371.4M
$351.2M
Net Profit
DHC
DHC
PEGA
PEGA
Q1 26
$32.8M
Q4 25
$-21.2M
$234.6M
Q3 25
$-164.0M
$43.4M
Q2 25
$-91.6M
$30.1M
Q1 25
$-9.0M
$85.4M
Q4 24
$-87.4M
$119.1M
Q3 24
$-98.7M
$-14.4M
Q2 24
$-97.9M
$6.6M
Gross Margin
DHC
DHC
PEGA
PEGA
Q1 26
75.2%
Q4 25
79.5%
Q3 25
72.2%
Q2 25
71.5%
Q1 25
78.5%
Q4 24
79.1%
Q3 24
70.2%
Q2 24
72.4%
Operating Margin
DHC
DHC
PEGA
PEGA
Q1 26
8.6%
Q4 25
-12.6%
20.7%
Q3 25
-43.4%
3.8%
Q2 25
-24.5%
4.5%
Q1 25
-2.7%
26.7%
Q4 24
-26.1%
29.1%
Q3 24
-26.5%
-3.6%
Q2 24
-23.0%
3.7%
Net Margin
DHC
DHC
PEGA
PEGA
Q1 26
7.6%
Q4 25
-5.6%
46.5%
Q3 25
-42.2%
11.4%
Q2 25
-23.9%
7.8%
Q1 25
-2.3%
18.0%
Q4 24
-23.0%
24.3%
Q3 24
-26.4%
-4.4%
Q2 24
-26.3%
1.9%
EPS (diluted)
DHC
DHC
PEGA
PEGA
Q1 26
$0.18
Q4 25
$-0.09
$0.81
Q3 25
$-0.68
$0.24
Q2 25
$-0.38
$0.17
Q1 25
$-0.04
$0.91
Q4 24
$-0.37
$1.35
Q3 24
$-0.41
$-0.17
Q2 24
$-0.41
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHC
DHC
PEGA
PEGA
Cash + ST InvestmentsLiquidity on hand
$105.4M
$270.0M
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$1.7B
$705.9M
Total Assets
$4.4B
$1.6B
Debt / EquityLower = less leverage
1.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHC
DHC
PEGA
PEGA
Q1 26
$270.0M
Q4 25
$105.4M
$425.8M
Q3 25
$201.4M
$351.4M
Q2 25
$141.8M
$411.6M
Q1 25
$302.6M
$371.7M
Q4 24
$144.6M
$740.0M
Q3 24
$256.5M
$703.0M
Q2 24
$265.6M
$665.1M
Total Debt
DHC
DHC
PEGA
PEGA
Q1 26
Q4 25
$2.4B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Stockholders' Equity
DHC
DHC
PEGA
PEGA
Q1 26
$705.9M
Q4 25
$1.7B
$787.4M
Q3 25
$1.7B
$596.8M
Q2 25
$1.9B
$624.5M
Q1 25
$1.9B
$611.3M
Q4 24
$2.0B
$585.5M
Q3 24
$2.0B
$473.0M
Q2 24
$2.1B
$435.4M
Total Assets
DHC
DHC
PEGA
PEGA
Q1 26
$1.6B
Q4 25
$4.4B
$1.6B
Q3 25
$4.7B
$1.3B
Q2 25
$4.8B
$1.3B
Q1 25
$5.0B
$1.3B
Q4 24
$5.1B
$1.8B
Q3 24
$5.3B
$1.6B
Q2 24
$5.3B
$1.5B
Debt / Equity
DHC
DHC
PEGA
PEGA
Q1 26
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
1.56×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHC
DHC
PEGA
PEGA
Operating Cash FlowLast quarter
$-19.6M
Free Cash FlowOCF − Capex
$-166.4M
$206.5M
FCF MarginFCF / Revenue
-43.8%
48.0%
Capex IntensityCapex / Revenue
38.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-280.3M
$494.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHC
DHC
PEGA
PEGA
Q1 26
Q4 25
$-19.6M
$158.4M
Q3 25
$-49.3M
$56.3M
Q2 25
$53.0M
$86.3M
Q1 25
$-3.2M
$204.2M
Q4 24
$112.2M
$95.2M
Q3 24
$21.1M
$30.5M
Q2 24
$44.3M
$40.1M
Free Cash Flow
DHC
DHC
PEGA
PEGA
Q1 26
$206.5M
Q4 25
$-166.4M
$152.4M
Q3 25
$-89.8M
$51.8M
Q2 25
$18.8M
$84.1M
Q1 25
$-42.9M
$202.3M
Q4 24
$-89.5M
$92.4M
Q3 24
$-26.1M
$27.4M
Q2 24
$3.3M
$38.8M
FCF Margin
DHC
DHC
PEGA
PEGA
Q1 26
48.0%
Q4 25
-43.8%
30.2%
Q3 25
-23.1%
13.6%
Q2 25
4.9%
21.9%
Q1 25
-11.1%
42.5%
Q4 24
-23.6%
18.8%
Q3 24
-7.0%
8.4%
Q2 24
0.9%
11.1%
Capex Intensity
DHC
DHC
PEGA
PEGA
Q1 26
Q4 25
38.7%
1.2%
Q3 25
10.4%
1.2%
Q2 25
8.9%
0.6%
Q1 25
10.2%
0.4%
Q4 24
53.1%
0.6%
Q3 24
12.6%
0.9%
Q2 24
11.0%
0.4%
Cash Conversion
DHC
DHC
PEGA
PEGA
Q1 26
Q4 25
0.68×
Q3 25
1.30×
Q2 25
2.87×
Q1 25
2.39×
Q4 24
0.80×
Q3 24
Q2 24
6.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

PEGA
PEGA

Pega Cloud$205.0M48%
Subscription license$94.9M22%
Maintenance$75.3M18%
Consulting$54.8M13%

Related Comparisons